Skip to content
  • Home
  • IOncology
  • Infectious Desease Frontier
  • IHepatology
  • Hematology Frontier
  • Conference topics
  • Experts Interviews
  • Informations
  • Live Broadcasting
  • Logout
MediaMedic

Connecting Medical Expertise through Media

  • Home
  • IOncology
  • Infectious Disease Frontier
  • International Hepatology
  • Hematology Frontier
  • Conference topics
  • Experts’ Interviews
  • Informations
  • Home
  • IOncology
  • Infectious Disease Frontier
  • International Hepatology
  • Hematology Frontier
  • Conference topics
  • Experts’ Interviews
  • Informations

# Dr. Rena K. Fox

Home » # Dr. Rena K. Fox
How to improve linkage between patients and treatment?

How to improve linkage between patients and treatment?

Posted by By Xiaorong JI 2024.02.19
<Hepatology Digest>: After a positive HCV screen, how can we effectively link patients to treatment services and overcome potential barriers?
Read More
How to improve HCV screening?

How to improve HCV screening?

Posted by By Xiaorong JI 2024.02.18
<Hepatology Digest>: Which populations should priority be given for HCV screening, and how can we improve screening rates to ensure early detection and treatment?
Read More
The U.S. Experience in HCV Screening, Linkage, and Treatment

The U.S. Experience in HCV Screening, Linkage, and Treatment

Posted by By Xiaorong JI 2024.01.31
Read More
Recent Posts
  • EAU26 Afternoon Tea Dialogue | Prof. Jianming Guo’s Team: Disease-Specific AI Large Model Enables Precise Preoperative Assessment of Renal Cancer
  • Voice of China at ASCO-GU | Prof. Haige Chen and Prof. Ruiyun Zhang: Renji Hospital’s Urothelial Carcinoma Team Showcases Multiple Studies on the International Stage, Advancing Bladder-Preserving Therapy and Liquid Biopsy
  • EAU26 Afternoon Tea Dialogue | Prof. Jianming Guo’s Team: Hormone Therapy Combined with Cytoreductive Surgery Offers a New Strategy for Oligometastatic Prostate Cancer
  • World Kidney Day 2026 | Prof. Lei Liu: Challenges and Strategies in Preventing and Managing Infections After Kidney Transplantation
  • ASCO-GU Expert Insights | Prof. Darren Poon Interprets the BRCAAway Study: Median OS Reaches 68 Months with First-Line PARP Inhibitor Therapy in mCRPC
Recent Comments
    Archives
    • March 2026
    • February 2026
    • January 2026
    • December 2025
    • November 2025
    • October 2025
    • September 2025
    • August 2025
    • July 2025
    • June 2025
    • May 2025
    • April 2025
    • March 2025
    • February 2025
    • January 2025
    • December 2024
    • November 2024
    • October 2024
    • September 2024
    • August 2024
    • July 2024
    • June 2024
    • May 2024
    • April 2024
    • March 2024
    • February 2024
    • January 2024
    • December 2023
    • November 2023
    • October 2023
    • August 2023
    Categories
    • Artificial intelligence
    • Hematology Frontier
    • Infectious Disease Frontier
    • International Hepatology
    • IOncology
    • Live broadcasting
    • Uncategorized
    • UroStream
    • LinkedIn
    • Twitter
    • Mail
    Related Media:
    Copyright 2026 — MediaMedic. All rights reserved. Blogun WordPress Theme
    Paris, France
    Scroll to Top